replic
strongli
enhanc
small
membran
protein
call
viru
protein
u
vpu
vpu
achiev
task
interact
receptor
b
amplifi
particl
releas
site
plasma
membran
first
role
due
interact
cytoplasm
site
vpu
second
role
may
due
ion
channel
activ
caus
selfassembl
protein
recent
blocker
propos
abolish
channel
activ
chapter
mechan
block
describ
use
comput
method
includ
brief
overview
viral
ion
channel
blocker
discoveri
structur
function
protein
goe
mostli
parallel
wish
also
need
find
potenti
modul
inhibit
discov
function
especi
case
viral
protein
sever
textbook
discoveri
describ
literatur
gener
review
see
blundel
et
al
sole
ration
approach
potenti
drug
design
proteas
lam
et
al
review
see
wlodaw
erickson
hodg
et
al
influenza
neuraminidas
von
itzstein
et
al
base
respect
crystal
structur
varghes
et
al
baumeist
et
al
even
recent
exampl
compris
discoveri
inhibitor
main
proteas
pro
sar
viru
applic
structurebas
comput
approach
yang
et
al
protein
involv
proteolyt
process
transcrib
protein
essenti
viral
life
cycl
highresolut
data
around
obtain
presenc
hexapeptidyl
inhibitor
cbzvalasnserthrleuglncmk
reveal
bind
conform
drug
addit
structur
record
differ
ph
reveal
larg
structur
arrang
protein
upon
chang
ioniz
state
exampl
one
protein
neuraminidas
membran
protein
see
chapter
garman
laver
book
date
antivir
drug
found
two
membran
protein
includ
viru
adsorpt
inhibitor
eg
viruscel
fusion
inhibitor
like
peptid
root
et
al
review
see
de
clercq
howev
resist
develop
drug
eg
case
proteas
condra
et
al
necessit
hunt
target
smaller
socal
accessori
protein
includ
also
membran
protein
see
miller
sarver
compar
larger
solubl
protein
seen
highli
structur
candid
larg
surfac
area
put
bind
motif
discov
membran
protein
compris
difficult
target
due
difficulti
obtain
enough
structur
inform
access
region
loop
desir
prerequisit
fast
drug
discoveri
recent
attempt
deriv
rel
larg
quantiti
full
length
short
viral
membran
protein
amino
acid
appli
standard
solid
phase
peptid
synthesi
spp
success
achiev
influenza
et
al
two
end
protein
synthes
chemic
ligat
obtain
fulllength
protein
claim
method
even
noncod
amino
acid
incorpor
would
mean
case
vpu
two
phosphoryl
serin
would
need
ad
despit
still
miss
experiment
verif
method
play
import
role
futur
obtain
suffici
quantiti
small
protein
gener
kochendoerf
et
al
howev
far
structur
inform
emerg
gradual
investig
part
whole
vpu
may
serv
exampl
cd
ftir
nmr
spectroscopi
see
chapter
opella
et
al
beching
henklein
respect
book
carri
part
vpu
exampl
transmembran
tm
part
variou
length
sole
cytoplasm
part
therebi
fragment
produc
either
spp
express
methodolog
structur
inform
suffici
enabl
gener
comput
model
model
especi
model
repres
tm
segment
vpu
embed
hydrophob
slab
surround
octan
mimic
lipid
bilay
fulli
hydrat
lipid
bilay
atom
basi
review
fischer
recent
even
fulllength
model
base
structur
inform
fragment
produc
embed
lipid
monolay
sun
model
use
dock
approach
molecular
dynam
md
simul
enabl
detail
structur
analysi
highresolut
data
avail
highresolut
structur
avail
method
may
furthermor
use
refin
static
structur
predict
protein
mechan
put
drugprotein
interact
chapter
effort
obtain
inform
drugprotein
interact
vpu
summar
compar
investig
short
viral
membran
protein
emphasi
outlin
comput
method
use
enterpris
demonstr
potenti
drug
discoveri
especi
case
vpu
highresolut
structur
yet
avail
vpu
amino
acid
protein
encod
high
degre
sequenc
conserv
willbold
et
al
role
structur
report
detail
chapter
book
brief
function
life
cycl
fold
review
see
fischer
sansom
bour
strebel
fischer
montal
interact
endoplasm
reticulum
initi
ubiquinin
mediat
degrad
complex
b
enhanc
particl
releas
site
plasma
membran
alter
electrochem
gradient
via
ion
channel
format
homo
oligomer
lipid
membran
interact
ion
channel
hsu
et
al
first
function
fairli
establish
second
still
open
debat
lamb
pinto
exampl
known
whether
ion
channel
activ
intrins
part
vpu
function
howev
vpu
either
tm
domain
synthes
use
spp
fulllength
protein
express
reconstitut
lipid
bilay
show
channel
activ
schubert
et
al
marassi
et
al
cord
et
al
park
et
al
recent
drug
describ
block
channel
activ
vpu
vitro
ewart
et
al
also
hepat
c
viru
premkumar
et
al
molecul
caus
effect
deriv
amilorid
cyclohexamethylen
amilorid
spectroscop
studi
vpu
incorpor
membran
mimic
membran
use
cd
wray
et
al
wray
et
al
ftir
kukol
arkin
nmr
spectroscopi
federau
et
al
willbold
et
al
et
al
identifi
structur
element
allow
follow
descript
vpu
structur
helic
tm
segment
follow
larger
cytoplasm
domain
helixloop
helixhelixturn
motif
cytoplasm
domain
seem
contact
membran
marassi
et
al
henklein
et
al
zheng
et
al
tilt
angl
tm
segment
respect
membran
normal
use
differ
techniqu
vpu
construct
found
rang
approxim
kukol
arkin
marassi
et
al
wray
et
al
henklein
et
al
recent
nmr
spectroscop
studi
indic
kink
tm
segment
around
residu
park
et
al
base
experiment
result
sever
model
vpu
propos
comput
simul
grice
et
al
cord
et
al
lopez
et
al
sramala
et
al
sun
detail
vpu
reader
may
refer
chapter
sj
opella
et
al
wray
schubert
b
beching
p
henklein
p
gage
et
al
respect
book
dock
approach
proven
valuabl
tool
identifi
drugbind
site
protein
also
screen
larg
databas
potenti
drug
bind
site
known
blundel
et
al
glick
et
al
dock
method
protein
ligand
transfer
point
grid
smaller
space
grid
increas
accuraci
method
proce
parallel
increas
comput
time
calcul
pioneer
work
field
achiev
peter
goodford
goodford
boobyer
et
al
wade
et
al
method
put
dock
site
potenc
differ
conform
drug
assess
base
calcul
electrostat
interact
date
sever
dock
softwar
avail
differ
function
implement
evalu
fit
score
drug
bind
site
score
function
principl
protein
drug
held
rigid
calcul
save
comput
time
advanc
method
allow
ligand
flexibl
wang
et
al
kua
et
al
even
protein
carlson
mccammon
anoth
improv
dock
approach
introduct
energi
solvat
ligand
evalu
bind
affin
consequ
score
shoichet
et
al
present
studi
autodock
morri
et
al
use
lamarckian
genet
algorithm
ga
appli
ligand
explor
randomli
translat
orient
conform
space
respect
rigid
protein
avoid
extrem
cpu
time
due
endless
number
possibl
combin
search
ga
combin
local
search
ls
protocol
allow
energi
minim
low
temperatur
howev
gener
drawback
dock
softwar
inabl
includ
electrostat
contribut
lipid
bilay
environ
md
simul
per
se
describ
chang
posit
veloc
orient
system
time
base
newtonian
principl
trajectori
time
averag
macroscop
properti
deduc
screen
protein
surfac
drug
ligand
would
cost
almost
endless
md
simul
time
would
impos
softwar
failur
consequ
inaccur
result
move
ligand
around
protein
surfac
might
envisag
use
artifici
forc
ligand
steer
md
simul
step
direct
use
till
date
protein
fold
lu
et
al
gao
et
al
propos
pathway
molecul
known
bide
site
kosztin
et
al
isralewitz
et
al
shen
et
al
workaround
combin
use
dock
approach
follow
md
simul
molecular
mechan
calcul
wang
et
al
beierlein
et
al
howev
use
sole
md
simul
explor
drug
protein
becom
increasingli
valuabl
tool
recent
investig
effect
gener
anesthet
ion
channel
gramicidin
investig
tang
xu
studi
miss
local
chang
protein
caus
drug
correl
low
affin
gener
anesthet
target
anoth
approach
effect
mutat
structur
integras
analyz
use
md
simul
barreca
et
al
simul
also
done
presenc
inhibitor
address
drugprotein
interact
present
chapter
put
bind
site
amilorid
cyclohexamethylen
amilorid
hma
tm
domain
vpu
deriv
dock
approach
dock
approach
pentamer
bundl
use
discov
bind
site
simul
run
protein
bundledrug
complex
ns
topolog
drug
partial
atom
charg
determin
prodrug
van
aalten
et
al
adapt
forc
field
accord
result
shown
experiment
ewart
et
al
hma
lesser
extent
dimethyl
amilorid
block
channel
activ
fulllength
vpu
reconstitut
lipid
membran
peptid
repres
tm
domain
protein
almost
neglig
effect
data
hand
larg
amount
structur
data
avail
see
fischer
refer
therein
park
et
al
comput
method
approach
address
follow
question
locat
put
bind
site
affin
blocker
b
dynam
blocker
bind
site
block
mechan
c
entri
bind
site
question
blocker
bind
address
use
dock
program
even
though
design
search
within
porelik
structur
present
studi
program
autodock
use
potent
blocker
hma
proton
hma
like
form
physiolog
conditionsand
unproton
hma
form
c
kim
v
lemaitr
watt
wb
fischer
prepar
vpu
model
use
singlestrand
vpu
correspond
tm
helix
vpu
vpu
figur
extend
kink
model
vpu
model
assembl
helic
form
pentamer
hexamer
bundl
gener
also
use
dock
approach
singl
peptid
ration
idea
possibl
bind
mechan
blocker
bind
prior
format
ion
conduct
bundl
result
summar
way
put
bind
site
toward
c
termin
end
peptid
case
bundl
within
pore
specif
residu
blocker
establish
contact
type
interact
via
hydrogen
bond
calcul
bind
constant
found
rang
deriv
experi
fischer
lam
watt
fischer
unpublish
result
base
find
md
simul
may
follow
address
dynam
blocker
protein
almost
realist
environ
hydrat
lipid
bilay
lemaitr
et
al
studi
membran
protein
embed
hydrat
lipid
bilay
highli
success
describ
mechan
function
ion
channel
atom
level
tieleman
et
al
sansom
et
al
shrivastava
sansom
bernech
roux
de
groot
im
roux
zhu
et
al
base
find
dock
approach
cyclohexamethylen
amilorid
amilorid
proton
deproton
sate
place
within
pentamer
bundl
figur
whole
system
place
hydrat
lipid
bilay
analysi
give
insight
effect
blocker
protein
structur
analysi
data
reveal
major
structur
rearrang
helic
detail
analysi
pore
bundl
subdivid
three
region
ntermin
residu
middl
residu
ctermin
section
residu
data
uncov
small
structur
sort
allow
follow
interpret
amilorid
induc
widen
pore
cyclohexamethylen
induc
funnellik
shape
narrow
part
ntermin
end
princip
compon
analysi
pca
appli
determin
concert
motion
take
place
bundl
simul
figur
pca
amadei
et
al
sometim
call
essenti
dynam
allow
find
correl
motion
within
object
exampl
protein
garcia
wong
et
al
van
aalten
et
al
yang
et
al
grottesi
sansom
correl
motion
princip
compon
shown
describ
motion
relev
function
protein
techniqu
involv
remov
overal
rotat
translat
isol
intern
motion
achiev
least
squar
fit
refer
structur
comput
covari
matrix
c
atom
coordin
princip
compon
obtain
diagon
matrix
c
orthonorm
transform
amadei
et
al
atom
consid
analysi
vpu
bundl
atom
enabl
nois
aris
random
motion
side
chain
remov
reduc
size
matric
need
diagon
furthermor
analysi
perform
equilibr
part
trajectori
discard
first
nanosecond
figur
show
first
princip
motion
largest
amplitud
bundl
indic
arrow
motion
describ
correl
chang
twist
kink
individu
helic
form
pore
vpu
bundl
without
blocker
figur
vpu
bundl
presenc
figur
main
correl
motion
presenc
hma
figur
describ
concert
chang
tilt
angl
two
helic
indic
closur
pore
final
explain
funnellik
shape
mode
block
also
includ
occlus
within
pore
occlud
complet
hma
hma
almost
complet
occupi
space
within
pore
figur
vicin
least
one
serin
appar
minimum
pore
radiu
left
within
middl
section
hma
latter
valu
small
even
allow
singl
file
water
roux
karplu
woolley
wallac
chiu
et
al
de
groot
et
al
pass
blocker
water
molecul
peptid
antibiot
gramicidin
assum
pass
pore
singl
file
way
mean
one
water
molecul
neighbor
front
back
rootmeansquar
deviat
rmsd
valu
blocker
remain
nm
slightli
higher
valu
hma
hma
largest
fluctuat
latter
data
shown
larger
valu
spread
indic
amilorid
deriv
flexibl
cyclohexamethylen
ring
root
mean
squar
fluctuat
rmsf
individu
atom
blocker
indic
central
bodi
pyrazin
ring
hma
remain
fairli
rigid
rmsf
nm
independ
proton
state
blocker
hydrogen
atom
amino
group
pyrazin
ring
guanidinium
group
show
largest
fluctuat
nm
curv
albeit
similar
blocker
compar
similar
atom
adopt
slightli
lower
valu
atom
proton
blocker
cyclohexamethylen
ring
hma
fluctuat
around
nm
independ
proton
state
thu
hexamethylen
ring
add
mobil
part
rigid
pyrazin
ring
differ
conform
gener
md
simul
blocker
test
cluster
use
full
linkag
algorithm
use
cutoff
nm
nm
hma
case
mean
molecul
rmsd
smaller
nm
rel
exist
member
cluster
belong
cluster
mostli
popul
conform
shown
figur
frequent
adopt
conform
hma
figur
carbonyl
group
link
guanidinium
group
proton
blocker
point
toward
primari
amin
group
pyrazin
ring
deproton
blocker
reveal
conform
chang
blocker
amin
part
guanidinium
group
point
primari
amin
group
pyrazin
ring
data
shown
blocker
independ
proton
state
interact
protein
via
hydrogen
bond
hydrogen
bond
partner
serin
side
chain
point
pore
therefor
promin
differ
hma
addit
hydrogen
bond
hma
also
interact
one
tryptophan
come
resid
helixhelix
helixlipid
interfac
caus
interact
might
due
lower
averag
veloc
hma
within
site
addit
dynam
affect
hma
orient
hydrophob
cyclomethylen
ring
stronger
hydrophob
part
pore
toward
ntermin
end
reflect
averag
angl
hma
hma
respect
membran
plane
adopt
angl
respect
larger
standard
deviat
reflect
higher
flexibl
within
pore
md
simul
base
result
obtain
dock
approach
perform
autodock
softwar
blocker
place
site
suggest
autodock
question
aris
would
md
simul
abl
deliv
result
order
address
question
seri
ns
simul
perform
pentamer
bundl
hma
differ
posit
along
zaxi
within
pore
pentamer
bundl
figur
result
term
stabil
bundl
overal
structur
remain
similar
result
long
simul
data
shown
integr
bundl
destroy
independ
posit
blocker
interest
note
posit
one
use
longer
simul
posit
site
blocker
leav
start
posit
ns
put
individu
pictur
context
posit
hma
toward
cor
ntermin
end
bundl
may
forc
blocker
orient
long
axi
parallel
pore
axi
beyond
certain
threshold
posit
even
escap
pore
comput
approach
alway
judg
relev
result
stand
fall
model
assum
case
question
allow
realist
bundl
experiment
studi
propos
vpu
exist
oligom
maldarelli
et
al
comput
experi
sole
tm
segment
undertaken
relat
experiment
deriv
cation
select
vpu
number
segment
form
bundl
grice
et
al
studi
low
energi
k
pass
pore
compar
higher
valu
obtain
cl
pentamer
bundl
support
idea
pentamer
model
combin
experiment
comput
approach
tetramer
bundl
exclud
put
pore
cord
et
al
howev
direct
structur
evid
still
lack
thu
vpu
could
also
tetram
unless
proven
exampl
xray
spectroscopi
otherwis
thu
investig
carri
pentamer
hexamer
bundl
overal
orient
helic
serin
face
lumen
pore
base
find
ion
channel
leonard
et
al
galzi
et
al
pebaypeyroula
et
al
pautsch
schulz
sass
et
al
recent
solidst
nmr
spectroscop
investig
propos
kink
around
park
et
al
comput
model
gener
without
explicit
kink
howev
analysi
bundl
use
residu
center
point
also
reveal
averag
kink
helic
differ
absolut
valu
may
deriv
differ
lipid
use
length
peptid
includ
addit
residu
ctermin
end
enabl
facilit
purif
site
bind
moment
pure
comput
base
specul
howev
may
bring
site
context
experiment
evid
diaminomethylen
pyrazinecarboxamid
moder
strong
base
pk
schellenberg
et
al
kleyman
crago
physiolog
ph
least
exist
posit
charg
form
due
proton
guanidinium
group
crago
et
al
case
epitheli
na
channel
proton
form
essenti
block
indic
phdepend
activ
kleyman
crago
solubl
water
mm
beno
deproton
form
lipid
solubl
easili
cross
cell
membran
consequ
accumul
within
cell
alter
number
cellular
process
beno
kleyman
crago
grinstein
et
al
metabol
bodi
elimin
intact
urin
biolog
halflif
hr
smith
smith
deriv
class
potent
blocker
na
transport
epitheli
na
channel
enac
na
h
exchang
lesser
extent
na
ca
exchang
crago
cyclohexamethylen
amilorid
report
especi
select
na
h
exchang
kleyman
crago
hydrophob
interact
part
channel
adjac
bind
site
increas
bind
affin
blocker
garti
palmer
put
bind
site
na
channel
propos
approxim
within
tm
electr
field
li
et
al
fyfe
canessa
extracellular
side
beno
orient
propos
allow
guanidinium
group
penetr
pore
review
alvarez
de
la
rosa
et
al
use
antiam
antibodi
six
amino
acid
sequenc
wyrfhi
extracellular
loop
wyklhi
subunit
wyhfhi
subunit
kieberemmo
et
al
waldmann
et
al
ismailov
et
al
schild
et
al
identifi
put
bind
site
replac
second
subunit
glutam
abolish
block
replac
arginin
increas
block
anoth
point
mutat
within
tm
region
replac
crucial
serin
residu
also
abolish
affin
waldmann
et
al
indic
sequenc
includ
aromat
residu
posit
charg
residu
serin
vicin
hydrophob
site
key
featur
bind
deriv
consequ
bind
site
propos
guanidinium
group
vicin
serin
put
pore
vpu
present
studi
agreement
find
enac
also
local
anesthet
reflect
amilorid
overal
structur
penetr
pore
nicotin
acetylcholin
receptor
induc
block
via
occlus
neher
steinbach
bind
site
blocker
also
procain
adam
propos
site
within
pore
near
ring
serin
threonin
found
pore
receptor
leonard
et
al
base
experiment
find
comput
experi
use
mont
carlo
minim
method
perform
model
nachr
base
tm
helic
tikhonov
zhorov
data
analyz
bind
geometri
exampl
chlorpromazin
cpz
found
charg
group
interact
side
chain
serin
threonin
uncharg
group
interact
ring
hydrophob
residu
blocker
orient
long
axi
along
axi
bundl
due
amphiphat
charact
drug
result
indic
gener
pattern
bind
behavior
underlin
relev
result
obtain
deriv
present
studi
one
import
factor
discoveri
potenti
blocker
drug
also
knowledg
blocker
reach
bind
site
diffus
drug
rate
site
away
rate
involv
defin
bind
constant
et
al
also
essenti
know
correct
descript
energet
within
narrow
geometri
pore
indirect
method
like
brownian
dynam
steer
md
calcul
free
energi
reaction
path
method
may
give
reason
pictur
diffus
blocker
pore
method
need
taken
account
improv
understand
mechan
block
success
virtual
drug
screen
pore
blocker
gener
bundl
final
hydrat
bilay
system
water
molecul
found
within
pore
howev
ps
equilibr
step
total
escap
reenter
pore
simul
entir
durat
simul
hydrophil
ctermin
end
engulf
water
reach
serin
blocker
toward
ntermin
end
water
molecul
remain
within
pore
simul
bundl
vpu
consist
peptid
repres
tm
sequenc
iaiva
lvvaiiiaiv
vwsivii
indic
reduc
number
water
molecul
toward
ctermin
end
earli
stage
simul
lopez
et
al
pentamer
hexamer
bundl
embed
octan
slab
mimic
lipid
bilay
longrang
electrostat
interact
treat
ewald
sum
find
indic
fluctuat
number
water
molecul
within
pore
recent
investig
theoret
hydrophob
pore
model
show
presenc
water
pore
strongli
depend
pore
radiu
beckstein
sansom
nm
water
densiti
found
decreas
almost
zero
water
molecul
bigger
nm
travers
pore
avalanchelik
fashion
beckstein
sansom
small
radii
simul
long
timescal
ns
need
assess
proper
behavior
water
molecul
confin
geometri
thu
vpu
bundl
model
present
show
proper
bundl
temporari
state
low
water
content
use
md
simul
drug
screen
membran
protein
still
need
test
simul
still
time
consum
impos
major
drawback
compar
dock
approach
howev
possibl
implement
realist
condit
upon
model
membran
protein
within
bilay
allatom
represent
includ
explicit
represent
solvent
futur
overcom
exist
disadvantag
advanc
softwar
hardwar
mangoni
et
al
meantim
combin
md
simul
dock
approach
proven
power
tool
lead
discoveri
wang
et
al
kua
et
al
md
simul
drug
increasingli
play
import
role
explor
dynam
ligand
impact
protein
structur
tang
xu
vpu
identifi
potenti
drug
target
identif
residu
involv
block
action
help
ration
drug
design
one
earliest
antivir
drug
amantadin
also
remantadin
davi
et
al
hoffmann
known
target
viral
proton
channel
influenza
wang
et
al
latter
especi
use
chemoprophylaxi
therapi
influenza
site
block
assum
within
lumen
pore
residu
involv
duff
ashley
pinto
et
al
duff
et
al
detail
review
see
chapter
tang
et
al
book
also
nb
influenza
b
membran
protein
form
ion
channel
block
amantadin
sunstrom
et
al
fischer
et
al
howev
bind
constant
propos
block
high
propos
nb
potenti
target
short
viral
membran
protein
hepat
c
viru
also
exhibit
ion
channel
activ
griffin
et
al
pavlov
et
al
channel
amantadin
seem
block
channel
activ
griffin
et
al
howev
could
shown
channel
also
block
longalkylchain
iminosugar
deriv
pavlov
et
al
structur
consequ
comput
data
still
need
produc
get
insight
put
bind
site
blocker
vpu
anoth
viral
ion
channel
form
protein
number
hiv
protein
target
enlarg
discoveri
deriv
potenti
channel
blocker
ewart
et
al
see
also
chapter
p
gage
et
al
book
deriv
amantadin
spiro
analog
identifi
weak
activ
kolocouri
et
al
sinc
activ
encod
vpu
tempt
assum
block
either
one
two
role
vpu
infect
cell
possibl
viral
ion
channel
protein
viroporin
may
becom
highli
import
futur
drug
target
might
begin
fruit
time
respect
remain
specul
potenti
ligandbind
site
deriv
might
cytoplasm
part
vpu
beauti
approach
would
also
inhibit
vpu
function
initi
degrad
also
particular
case
vpu
gener
futur
drug
design
take
consider
immedi
proxim
lipid
membran
small
viral
membran
protein
form
ion
channel
increasingli
line
fire
drug
target
protein
like
vpu
highli
conserv
howev
virus
antivir
drug
protein
alreadi
avail
mostli
protein
globular
rel
easili
access
moder
effort
crystalliz
membran
protein
still
remain
difficult
target
respect
hand
protein
like
vpu
need
assembl
fullfil
task
compris
anoth
challeng
find
proper
target
structur
seem
like
especi
function
ion
channel
small
protein
show
achil
heel
may
becom
potenti
target
